Personal Capital Advisors Corp Gilead Sciences, Inc. Transaction History

Personal Capital Advisors Corp

$20.6 Billion
Q4 2022

A detailed history of Personal Capital Advisors Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Personal Capital Advisors Corp holds 7,266 shares of GILD stock, worth $800,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,266

Previous 8,066 9.92%

Holding current value

$800,931

Previous $498,000 25.1%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $49,856 - $71,576	-800 Reduced 9.92%	7,266 $623,000
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $952 - $1,088	16 Added 0.2%	8,066 $498,000
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $8,369 - $9,426	145 Added 1.83%	8,050 $498,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $25,484 - $31,935	-440 Reduced 5.27%	7,905 $470,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $11,418 - $12,960	176 Added 2.15%	8,345 $606,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $211,463 - $228,145	3,124 Added 61.92%	8,169 $571,000
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $35,543 - $38,836	-560 Reduced 9.99%	5,045 $347,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $10,020 - $11,432	-167 Reduced 2.89%	5,605 $362,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $29,967 - $34,146	529 Added 10.09%	5,772 $336,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $8,942 - $11,243	144 Added 2.82%	5,243 $331,000
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $69,374 - $80,556	-959 Reduced 15.83%	5,099 $392,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $19,978 - $25,590	319 Added 5.56%	6,058 $406,000
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $39,005 - $42,904	633 Added 12.4%	5,739 $373,000
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $33.1 Million - $36.6 Million	-530,048 Reduced 99.05%	5,106 $323,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $3.96 Million - $4.44 Million	63,925 Added 13.57%	535,154 $36.2 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $4.46 Million - $5 Million	71,319 Added 17.83%	471,229 $30.6 Million
Q4 2018 Jan 16, 2019	SELL	$60.54 - $79.0 $3.96 Million - $5.17 Million	-65,400 Reduced 14.06%	399,910 $25 Million
Q3 2018 Oct 09, 2018	BUY	$71.28 - $78.92 $1.84 Million - $2.04 Million	25,825 Added 5.88%	465,310 $35.9 Million
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $3.16 Million - $3.69 Million	48,741 Added 12.47%	439,485 $31.1 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $28.5 Million - $34.7 Million	390,744 New	390,744 $29.5 Million

Others Institutions Holding GILD

# of Institutions

2,101

Shares Held

1.02B

Call Options Held

8.73M

Put Options Held

9.63M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $138B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

News

Stay updated on Personal Capital Advisors Corp with notifications on news.

Account

Personal Capital Advisors Corp Gilead Sciences, Inc. Transaction History